Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy

被引：0
|
作者：
C G McMahon
机构：
[1] Australian Centre for Sexual Health,
来源：
International Journal of Impotence Research | 2003年 / 15卷
关键词：
erectile dysfunction; priapism; sildenafil; tadalafil; penile injections;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：383 / 384
页数：1
相关论文
共 50 条
  • [11] Long-term oral phosphodiesterase-5 inhibitor therapy alleviates recurrent priapism
    Burnett, AL
    Bivalacqua, TJ
    Champion, HC
    Musicki, B
    JOURNAL OF UROLOGY, 2006, 175 (04): : 301 - 301
  • [12] REGIMENTED PHOSPHODIESTERASE TYPE 5 INHIBITOR USE REDUCES EMERGENCY DEPARTMENT VISITS FOR RECURRENT ISCHEMIC PRIAPISM
    Hou, L.
    Burnett, A.
    JOURNAL OF SEXUAL MEDICINE, 2021, 18 (03): : S64 - S65
  • [13] Is phosphodiesterase type 5 inhibitor use associated with condom breakage?
    Crosby, R.
    Yarber, W. L.
    Sanders, S. A.
    Graham, C. A.
    SEXUALLY TRANSMITTED INFECTIONS, 2009, 85 (05) : 404 - 405
  • [14] PHOSPHODIESTERASE TYPE 5 INHIBITOR USE IS NOT ASSOCIATED WITH BIOCHEMICAL RECURRENCE AFTER DEFINITIVE THERAPY FOR PROSTATE CANCER
    Leapman, Michael
    Nguyen, Hao
    Cowan, Janet
    Porten, Sima
    Meng, Maxwell
    Cooperberg, Matthew
    Carroll, Peter
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1043 - E1043
  • [15] Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism REPLY
    不详
    JOURNAL OF UROLOGY, 2021, 205 (02): : 553 - 553
  • [16] Is phosphodiesterase type 5 inhibitor use associated with condom breakage? Commentary
    Goldmeier, D.
    Richardson, D.
    SEXUALLY TRANSMITTED INFECTIONS, 2009, 85 (05) : 405 - 406
  • [17] Use of a visual analog scale to assess pain of injection with intracavernous injection therapy (vol 2, pg 428, 2005)
    Lane, BZ
    Ausmundson, SJ
    Butler, RS
    Zippe, CD
    Jones, JS
    Lakin, MM
    JOURNAL OF SEXUAL MEDICINE, 2005, 2 (04): : 589 - 589
  • [18] Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism EDITORIAL COMMENTS
    Montague, Drogo K.
    JOURNAL OF UROLOGY, 2021, 205 (02): : 552 - 553
  • [19] CESSATION OF PHOSPHODIESTERASE 5 INHIBITOR USE IN MEN WITH ERECTILE DYSFUNCTION FOLLOWING TESTOSTERONE THERAPY
    Lin, J. S.
    Pastuszak, A. W.
    Ohlander, S. J.
    Hakky, T. S.
    Lamb, D. J.
    Lipshultz, L., I
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (02): : E10 - E10
  • [20] INTRACAVERNOUS INJECTION (ICI) OF PGE1 FOR TREATMENT OF ED WHEN PDE5INHIBITOR THERAPY IS INEFFECTIVE OR CONTRAINDICATED
    Tai, T.
    Nagao, K.
    Nakajima, K.
    Ishiwatari, T.
    Kobayashi, H.
    Ishii, N.
    Fujime, M.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 225 - 225
12345